Craneware (LON:CRW) Hits New 1-Year High at $2,300.00

Craneware plc (LON:CRW - Get Free Report) reached a new 52-week high during trading on Thursday . The company traded as high as GBX 2,300 ($28.89) and last traded at GBX 2,275 ($28.58), with a volume of 60642 shares traded. The stock had previously closed at GBX 2,240 ($28.14).

Wall Street Analyst Weigh In

Separately, Berenberg Bank lifted their price target on shares of Craneware from GBX 2,300 ($28.89) to GBX 2,600 ($32.66) and gave the stock a "buy" rating in a research note on Monday, March 4th.

Craneware Stock Up 1.8 %

The firm has a market cap of £805.52 million, a price-to-earnings ratio of 10,790.48 and a beta of 0.13. The firm's fifty day moving average is GBX 2,181.99 and its two-hundred day moving average is GBX 1,925.17. The company has a debt-to-equity ratio of 19.15, a current ratio of 0.78 and a quick ratio of 1.00.

Craneware Cuts Dividend

The firm also recently declared a dividend, which was paid on Monday, April 15th. Shareholders of record on Thursday, March 21st were issued a GBX 13 ($0.16) dividend. This represents a yield of 0.62%. The ex-dividend date of this dividend was Thursday, March 21st. Craneware's payout ratio is 13,809.52%.

Craneware Company Profile

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Trisus pricing transparency software; Trisus Pricing Analyzer, a solution that simplifies and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity for the United States payors; Trisus Claims Informatics, a retrospective charge capture analytical application that identifies areas of risk for its team to investigate; Trisus Supply, a solution that improves supplies reimbursement; and InSight Audit, an audit management solution for government and commercial payors.